HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theodore C Pierson Selected Research

Human Influenza (Influenza)

1/2024C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire.
1/2020Characterization of a Species E Adenovirus Vector as a Zika virus vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Theodore C Pierson Research Topics

Disease

56Infections
01/2022 - 04/2002
13Virus Diseases (Viral Diseases)
03/2024 - 05/2004
10Flavivirus Infections
11/2021 - 12/2007
9Zika Virus Infection
04/2023 - 01/2016
8West Nile Fever
01/2019 - 03/2005
5Dengue (Dengue Fever)
11/2021 - 01/2011
4Viremia
12/2022 - 06/2004
3Yellow Fever
01/2016 - 05/2005
3Japanese Encephalitis
01/2016 - 05/2005
2Human Influenza (Influenza)
01/2024 - 01/2020
2COVID-19
10/2023 - 01/2021
2Communicable Diseases (Infectious Diseases)
04/2021 - 12/2020
2Coinfection
01/2018 - 11/2014
2Alzheimer Disease (Alzheimer's Disease)
03/2004 - 05/2003
1Encephalitis (Encephalitis, Rasmussen)
12/2018
1Vesicular Stomatitis
01/2018
1Fetal Death
07/2017
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2017
1Severe Dengue
12/2007
1Body Weight (Weight, Body)
07/2005
1St. Louis Encephalitis
05/2005

Drug/Important Bio-Agent (IBA)

27VaccinesIBA
10/2023 - 05/2008
24AntibodiesIBA
01/2024 - 03/2007
14Neutralizing AntibodiesIBA
11/2021 - 05/2005
14Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2004
11Monoclonal AntibodiesIBA
10/2023 - 03/2005
8EpitopesIBA
12/2022 - 12/2006
6Antiviral Agents (Antivirals)IBA
03/2024 - 07/2005
5Messenger RNA (mRNA)IBA
04/2023 - 01/2017
5DNA (Deoxyribonucleic Acid)IBA
12/2019 - 04/2002
4Immunoglobulin G (IgG)IBA
12/2022 - 11/2007
4mRNA VaccinesIBA
10/2019 - 01/2017
3Polysaccharides (Glycans)IBA
01/2019 - 12/2006
3Complement System Proteins (Complement)IBA
11/2011 - 12/2007
3IgG Receptors (Fc gamma RI)IBA
10/2009 - 12/2006
2Hemagglutinins (Hemagglutinin)IBA
01/2024 - 01/2020
2Immunoglobulin M (IgM)IBA
12/2022 - 11/2007
2AntigensIBA
12/2022 - 10/2019
2Lipid NanoparticlesIBA
04/2021 - 12/2020
2NucleosidesIBA
04/2021 - 12/2020
2DNA VaccinesIBA
12/2019 - 10/2019
2Glycoproteins (Glycoprotein)IBA
01/2018 - 02/2006
2RNA (Ribonucleic Acid)IBA
01/2017 - 01/2014
2Small Interfering RNA (siRNA)IBA
12/2013 - 06/2005
1SolutionsIBA
12/2022
1Combined VaccinesIBA
11/2021
1IronIBA
01/2021
1SulfurIBA
01/2021
1Broadly Neutralizing AntibodiesIBA
01/2021
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
01/2021
1LipidsIBA
10/2019
1A-Form DNA (A-DNA)IBA
10/2019
1Interferon Type IIBA
01/2019
1Heterophile AntibodiesIBA
11/2018
1Explosive Agents (Explosives)IBA
01/2018
1Viral RNAIBA
07/2017
1Histone MethyltransferasesIBA
01/2017
1EnzymesIBA
01/2017
13' Untranslated Regions (3' UTR)IBA
01/2017
1Blocking AntibodiesIBA
01/2017
1Immune Sera (Antisera)IBA
09/2015
1Fc Receptors (Fc Receptor)IBA
01/2014
1AGRO 100IBA
12/2013
1FurinIBA
11/2011
1Opsonin Proteins (Opsonins)IBA
11/2011
1LuciferasesIBA
01/2011
1MicroRNAs (MicroRNA)IBA
01/2011
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
08/2010
1AcidsIBA
07/2009
1Mannose (D-Mannose)IBA
12/2006
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
02/2006
1LectinsIBA
02/2006
1CarbohydratesIBA
02/2006
1Glycoside Hydrolase InhibitorsIBA
07/2005
1castanospermineIBA
07/2005
1Interferon-betaIBA
03/2005
1Enfuvirtide (Fuzeon)FDA Link
05/2004
1TAK 779IBA
05/2004
1Amyloid (Amyloid Fibrils)IBA
03/2004
1Cadherins (E-Cadherin)IBA
03/2004
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
05/2003
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2003

Therapy/Procedure

5Therapeutics
01/2021 - 03/2005
1Highly Active Antiretroviral Therapy (HAART)
06/2004